A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
Phase 2
Completed
- Conditions
- Stem Cell Transplant Complications
- Interventions
- Drug: Placebo Wipe
- First Posted Date
- 2017-01-25
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 50
- Registration Number
- NCT03030989
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life
Not Applicable
Completed
- Conditions
- Continous Flow Left Ventricular Device
- Interventions
- Procedure: Hemodynamic-Echo Ramp Testing -Procedure: Echo Guided Testing
- First Posted Date
- 2017-01-13
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 40
- Registration Number
- NCT03021239
- Locations
- 🇺🇸
Stanford Medical Center, Stanford, California, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸UC San Diego Medical Center, San Diego, California, United States
Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses
- First Posted Date
- 2017-01-13
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 5
- Registration Number
- NCT03021317
Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring
Not Applicable
Completed
- Conditions
- Sleep Quality
- Interventions
- Behavioral: Usual CareBehavioral: Risk Stratification
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 166
- Registration Number
- NCT03010774
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma
Phase 1
Completed
- Conditions
- Malignant Glioma of Brain
- Interventions
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 10
- Registration Number
- NCT03011671
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk
Not Applicable
Not yet recruiting
- Conditions
- Obesity
- Interventions
- Behavioral: Late Total Caloric IntakeBehavioral: Early Total Caloric Intake
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 100
- Registration Number
- NCT03000803
Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
Completed
- Conditions
- Adrenal Insufficiency
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 86
- Registration Number
- NCT03000231
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Preparing for Kidney Transplant by Attaining a Healthy Weight
Not Applicable
Active, not recruiting
- Conditions
- Kidney Transplant
- Interventions
- Other: ExerciseDietary Supplement: Diet Plan
- First Posted Date
- 2016-12-08
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 10
- Registration Number
- NCT02986243
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2020-06-25
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 3
- Registration Number
- NCT02985554
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
Early Phase 1
Completed
- Conditions
- Classical Hodgkin LymphomaB-cell Non-Hodgkin LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 12
- Registration Number
- NCT02981914
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath